Legal & General Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311M Sell
644,847
-75,409
-10% -$20M 0.07% 283
2026
Q1
$78.9M Buy
720,256
+187,184
+35% +$26.7M 0.02% 552
2025
Q4
$88.7M Buy
533,072
+248,122
+87% +$41.5M 0.02% 538
2025
Q3
$55.8M Sell
284,950
-73,595
-21% -$12.1M 0.01% 603
2025
Q2
$32.4M Buy
358,545
+103,507
+41% +$8.18M 0.01% 708
2025
Q1
$15.2M Buy
255,038
+195,520
+329% +$18.1M ﹤0.01% 920
2024
Q4
$7.88M Buy
59,518
+35,285
+146% +$3.31M ﹤0.01% 1319
2024
Q3
$1.27M Buy
24,233
+22,921
+1,747% +$1.08M ﹤0.01% 2150
2024
Q2
$79.4K Buy
+1,312
New +$91K ﹤0.01% 2747

Other funds holding ALAB

Legal & General Group's ALAB Position: Q2 2026 in Review

Legal & General Group reduced its Astera Labs (ALAB) stake by 10% in Q2 2026, selling an estimated $20M and leaving 644,847 shares worth $311M. The position accounts for 0.07% of the portfolio, ranked #283.

Legal & General Group first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Legal & General Group held 644,847 shares of Astera Labs worth $311M as of Q2 2026.
  • Legal & General Group sold 75,409 Astera Labs shares in Q2 2026, an estimated $20M.
  • Astera Labs made up 0.07% of Legal & General Group's portfolio in Q2 2026, its #283 holding.
  • Legal & General Group first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.